BOSTON & SHENZHEN, China--(BUSINESS WIRE)--Signet Therapeutics, a clinical-stage biotech company leveraging organoid- and AI-driven cancer drug discovery, announced that the U.S. Food and Drug ...
Gastric cancer, a significant global health burden, claims over 7% of cancer-related deaths annually. Although only 1-3% of cases have a genetic basis, understanding these genetic drivers is crucial ...
Hereditary gastric cancer syndromes encompass a group of genetically determined conditions that confer a markedly increased risk of developing gastric malignancies. Central to these syndromes is ...
Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...
Mutation of CDH1 gene results in dysfunction of E-cadherin and release of β-catenin to the cytoplasm. Wnt protein binds to cell surface frizzled receptor and leads to translocation of β-catenin from ...
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis ...
Metastatic stomach cancer is cancer that has spread beyond your stomach to distant tissues. Treatment generally focuses on extending your life and reducing symptoms. Metastatic stomach cancer is also ...
JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas, Nov. 28, 2023 – After losing her sister to a rare form of stomach cancer, a Brooke Army Medical Center respiratory therapist found out that she too ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback